FcRn-silencing of IL-12Fc prevents toxicity of local IL-12 therapy and prolongs survival in experimental glioblastoma
Michał Beffinger(University of Zurich), Johannes vom Berg(University of Zurich)
Cited by 3
Related Papers
HDR-based CRISPR/Cas9-mediated Knockout of PD-L1 in C57BL/6 Mice
|BIO-PROTOCOL|2023|1